Paraguay: Surrogacy Medical and Donor Rules
Short answer
Short answer. In Paraguay, distinguish general health-law duties, Ministry clinical standards and clinic policy. The official sources do not establish a comprehensive enacted surrogacy/ART code with a complete checklist for carrier eligibility, donor screening or anonymity, embryo storage, or compensation. This is a bounded finding, not proof that no other applicable instrument exists. A clinic’s willingness to treat is not legal approval and does not guarantee parentage, birth registration, nationality or travel documents. Verify the rules for the named clinic and procedure before treatment.
What the current materials show
The Ministry’s 2025 National Standards Manual, approved by Resolution S.G. No. 050 on 14 February 2025, defines assisted reproduction broadly enough to include donor semen, gamete cryopreservation and surrogacy cycles; it is not a complete statutory eligibility code. Official parliamentary records show two relevant 2025 proposals still pending: D-2586876 on access to assisted-reproduction techniques in the public health system (introduced 11 August 2025), and D-2586759 to create the national PRONARA programme (introduced 6 August 2025). Neither is enacted law, and proposed text is not a present legal requirement.
General rules
General rules that do apply. Paraguay’s Sanitary Code (Law No. 836) states that human reproduction must be practised freely and responsibly while protecting health from conception, and places reproductive-health programmes and services under Ministry supervision, with respect for fundamental rights and family dignity (Articles 18–19). These provisions are binding law, but their general wording does not supply a complete list of medical tests, donor exclusions, age limits, carrier parity requirements, genetic-screening rules or embryo-transfer limits for surrogacy. The Code also treats the pregnant woman and the developing human as a biological unit for health-protection purposes (Article 16). That health-protection language should not be stretched into a rule that settles contractual enforceability or legal parentage in a surrogacy case.
Clinic and staff
Clinic and professional status. The Sanitary Code gives the Ministry regulatory and inspection powers over health establishments; it includes prior-authorization requirements for relevant establishments and allows authorization to be cancelled where operation creates a health risk (Articles 88–89 and 100). Health professionals must hold the required qualification and be entered in the Ministry’s register (Article 215). Before paying or signing, obtain the clinic’s current health-establishment authorization, confirm the authorised address and services, and verify the registrations and relevant specialist credentials of the physician and laboratory personnel. Ask whether the authorisation expressly covers the proposed laboratory procedures, gamete handling and cryostorage. A general clinic permit is not, by itself, evidence that every reproductive technique or a surrogacy arrangement has been specifically licensed.
Consent is a legal baseline
Consent is a legal baseline, not a signature ritual. Article 24 of the Sanitary Code states that medical or dental care requires the person’s express consent, subject to specified exceptions. The provision does not, by itself, set out a complete surrogacy-specific consent form or a full list of disclosures for each reproductive procedure. As a practical safeguard, the carrier, each gamete donor and the intended parent or parents should receive information in a language they understand and should sign separate, procedure-specific records before medication, retrieval, fertilisation, embryo transfer or cryopreservation. Records should address foreseeable risks, alternatives, handling and storage of material, withdrawal before the relevant procedure where possible, confidentiality, data access, expenses and what happens if a cycle fails or a participant’s wishes change. Do not describe this recommended documentation checklist as a verbatim statutory form.
Clinical standards and eligibility
Clinical standards versus special legal eligibility. Resolution S.G. No. 050 of 14 February 2025 approved the Manual and ordered its application in establishments forming part of the National Health System. Chapter 12, “Management of the Infertile Couple,” defines medically assisted reproduction to include insemination with partner or donor semen and defines assisted-reproduction techniques to include gamete/embryo cryopreservation, donation and surrogacy cycles. It also sets out a general infertility work-up for couples: reproductive and medical history, examination, and assessment of ovulatory/endocrine, uterine/tubal and peritoneal factors; genetic, immunohaematological and psychological assessments are indicated selectively, not routinely. For semen analysis it gives reference values of volume above 1.4 mL, concentration above 16 million/mL, total count at least 39 million, progressive motility at least 30%, normal morphology above 4% and vitality above 54%; an abnormal result should be repeated after three months. These are infertility-assessment protocols and semen reference values, not a donor-screening panel or eligibility thresholds for a gestational carrier. The full Manual defines surrogacy but does not set a dedicated carrier-eligibility checklist or donor-screening protocol. Confirm whether the Manual applies to the specific establishment and request any additional current technical rules; local counsel should verify their legal scope before a test or exclusion is treated as mandatory.
Gestational-carrier assessment
Gestational-carrier assessment: what to verify. The official materials do not establish a single enacted Paraguayan checklist specifying the carrier’s maximum age, minimum number of previous births, mandatory waiting period, psychological-test format or exhaustive list of contraindications for surrogacy. Do not invent these thresholds or assume that another country’s rules apply. Clinically, the treating team should document a reasoned assessment of general health, obstetric history, uterine suitability, medicines, infection risks, relevant chronic conditions, mental-health support and the risks of pregnancy and delivery. These are prudent clinical assessment areas, not a claim that each item is prescribed by a Paraguay-specific surrogacy statute. Request the written medical protocol, the criteria used to accept or defer a candidate, how risks are explained, who makes the decision and how a second opinion can be obtained. The carrier’s consent and health interests remain central throughout treatment and pregnancy.
Egg and sperm donors
Egg and sperm donors: demand the actual screening protocol.The reviewed official sources do not establish a comprehensive ART-specific Paraguayan statutory list of infectious-disease tests, genetic tests, family-history exclusions, repeat-testing intervals or donor-age limits. That does not mean screening is unnecessary; it means the clinic must not present its own panel as a quoted statutory list without identifying the legal source. Before donor gametes are used, request the current protocol and ask which tests are performed, when samples are taken, how window-period risks are managed, what genetic and family-history information is collected, what findings exclude or defer a donor, and how results are reviewed and recorded. Confirm how donor identity is verified and how each sample is linked to the correct record and treatment cycle. A test menu alone is insufficient: ask who interprets abnormal or inconclusive results and whether the recipient and intended parents are told about residual risks and alternatives.
Anonymity, confidentiality and the child’s origins
Anonymity, confidentiality and the child’s origins. Do not promise that a donor can be permanently anonymous under Paraguayan law on the basis of clinic custom alone. The Children and Adolescents Code (Law No. 1680, Article 18) recognises a child’s right to a name, to remain with their parents and to pursue judicial investigation of their origins. The Civil Code separately regulates proof and challenges to filiation. Those provisions do not automatically resolve every donor-conception question, but they make it unsafe to assume that a private donor agreement conclusively overrides a child’s legal rights. Ask what identifying and non-identifying data are retained, who can access them, how long records are kept, how information is disclosed if a child later requests it, and how confidentiality is reconciled with court orders or statutory duties. Have Paraguayan counsel review the proposed donor-consent language and record-retention policy before treatment.
Donor compensation and reproductive-material handling
Paraguay has no complete special statutory regime for donor compensation, donor-use limits, storage duration, posthumous use or disposition of unused gametes/embryos. Do not infer legality from a clinic’s offer or contract. Before treatment, obtain written rules for storage, consent renewal, instructions for unused material, transport and traceability. Carrier compensation and the broader enforceability of the surrogacy agreement are separate contract questions and should be reviewed separately; this article does not decide them.
Medical eligibility is not legal parentage
Do not confuse medical eligibility with legal parentage. The Civil Code (Law No. 1183) regulates recognition, investigation, proof and challenge of filiation, including Articles 231–242. The provisions do not expressly set out a complete pathway for assigning parentage after a gestational-surrogacy birth or state that a surrogacy contract alone determines the birth record. Article 240 specifically permits a filiation challenge alleging a fictitious birth, child substitution, or that the woman is not the mother of the child attributed to her. An October 2026 ABC Color interview quotes Paraguayan lawyer Mirta Moragas as taking the view that, under the Civil Code, the woman who gestates and gives birth is the mother [S8]. The report does not identify a specific statutory clause for that proposition. Treat it as a significant local-law interpretation requiring confirmation, not as a stand-alone binding rule. Genetic links, clinic records, donor consent and the carrier agreement are distinct evidence; none alone resolves every parentage issue. Before creating embryos or transferring an embryo, obtain written advice on the likely registration route, any court application or consent needed, the status of the person who gives birth, and the documents the Civil Registry will actually accept.
Preserve the child’s identity and evidence
Build the child’s identity and evidence trail into the plan. Law No. 1680 protects a child’s identity and provides for birth registration; Article 18 recognises the right to investigate origins, and Article 19 addresses preservation of identity and health-establishment birth records. Civil Code Article 242 addresses how filiation is proved. These provisions do not prescribe a complete gamete-donor database for ART, but they make reliable records practically important. Keep the donor code, source and handling history of each gamete, consent versions, laboratory identifiers, embryo transfer records, pregnancy and birth records, and any parentage orders in a controlled file with an access log. Ask local counsel what retention period and disclosure rules apply. Never destroy or anonymise records solely because a clinic’s standard form says the donor is anonymous.
Legal status
| Subject | Legal status | Practical consequence |
|---|---|---|
| Sanitary Code, Law No. 836 | Binding general law | Reproductive-health oversight and express consent apply, but the cited provisions are not a complete ART or donor code. |
| Health establishment and professionals | Binding general law | Verify current establishment authorization and professional registration; do not assume a surrogacy-specific licence. |
| 2025 Gynaecological Standards Manual | Ministerial clinical standards | Applies within the National Health System and contains general infertility work-up and semen reference values, not a dedicated carrier-eligibility or donor-screening code. |
| Gamete screening, donor age and anonymity | No complete statutory list published (as of Oct 2026) | Obtain the clinic protocol and exact legal citation; distinguish clinical practice from binding law. |
| Parentage and child identity | Separate legal questions | Obtain a jurisdiction-specific parentage and birth-registration opinion before treatment. |
Document checklist
- Clinic authorisation and address.
- registration and specialist credentials of the treating physician and laboratory.
- the current medical protocol for the carrier and each donor.
- dated laboratory results and the person who interpreted them.
- separate informed-consent records for the carrier, each donor and intended parents.
- the donor-data, confidentiality and retention policy.
- sample and embryo identification/traceability records.
- written terms for fees, reimbursements, storage, cancellation and unused material.
- and written Paraguayan advice on birth registration and parentage. Request copies before treatment starts, not after a dispute arises.
Decision sequence
First, ask the clinic to cite each law, ministerial resolution or technical protocol it says governs the procedure. Verify the clinic and professionals with the Ministry’s relevant register or licensing office. Obtain current medical and donor protocols, written acceptance criteria, results and an explanation of residual risks. Ensure every participant receives understandable information and gives documented consent before the relevant intervention. Before the cycle, have Paraguayan family- and health-law counsel review anonymity, data retention, payments, embryo disposition, parentage and birth registration. If the clinic cannot substantiate a claimed legal requirement, treat it as internal policy pending verification; do not rely on oral assurances.
When to pause
Pause if the clinic will not show current authorisation; staff or laboratory credentials cannot be verified; donor tests are called legally mandatory without a citation or protocol; absolute anonymity is promised without discussing the child’s origin rights; consent is generic or signed after stimulation/retrieval; samples cannot be traced to the donor and cycle; fees or storage terms are unclear; or a contract is said to guarantee the intended parents’ names on the birth certificate. Before paying, starting medication or creating/transferring embryos, obtain written clarification and independent Paraguayan legal advice.
Bottom line
Bottom line. General health law, professional registration, express consent and child-identity/filiation rules apply. The reviewed official sources did not establish a complete special statutory checklist for carrier eligibility or donor screening. Neither assume nothing is regulated nor treat clinic policy as law. Before treatment, obtain the legal basis for each claimed mandatory criterion, current written protocols and traceable donor records, plus independent Paraguayan advice on parentage and birth registration.
Legal sources
The sources below support the propositions identified in the article. A listed source does not mean every question has been conclusively resolved.
- [S1] Ley Nº 836 / Código Sanitario
- [S2] Ley Nº 1183 / Código Civil
- [S3] Resolución S.G. Nº 050 (14 de febrero de 2025), que aprueba el Manual Nacional de Normas de Atención de Patologías Ginecológicas
- [S4] Expediente D-2586876 — Acceso integral a técnicas de reproducción asistida en el sistema público de salud (estado: EN TRÁMITE)
- [S5] Expediente D-2586759 — Programa Nacional de Reproducción Asistida (PRONARA; estado: EN TRÁMITE)
- [S6] Ley Nº 1680 / Código de la Niñez y la Adolescencia
- [S7] Manual Nacional de Normas de Atención de Patologías Ginecológicas, Primera Edición 2025 (texto completo)
- [S8] ABC Color — “Del revuelo por el primer ministro neerlandés a la realidad de la gestación subrogada en Paraguay” (secondary media report, October 2026)
Not legal clearance.
